Patricia Y Fechner, MD

Patricia Y Fechner, MD

Endocrinology and Diabetes, Differences in Sex Development, Turner Syndrome, Congenital Adrenal Hyperplasia Program

On staff since November 2006

Children's Title: Medical Director, DSD Program; Medical Director, CAH Program and Co-Director, Turner Syndrome Clinic

Academic Title: Professor, Pediatrics

Research Center: Center for Clinical and Translational Research

  • Biography

    Patricia Fechner, MD, is attending physician at Seattle Childrens Hospital and professor of pediatrics at the University of Washington School of Medicine. Her clinical and research interests include congenital adrenal hyperplasia, Turner syndrome, androgen insensitivity syndrome and other disorders of sex determination as well as growth hormone and IGF-1 deficiency. She is the Medical Director of the CAH Center of Excellence, Medical Director of the DSD program and Medical Co-Director of the Turner syndrome clinic. She serves as the contributing editor for the section of endocrinology AAP Grand Rounds and as contributer to the BMJ Clinical Practice Turner Syndrome section.

  • Patient Testimonials

  • Awards and Honors

    Award Name Award Description Awarded By Award Date
    SEATTLE TOP DOCTOR - 2022 Seattle Magazine 2022
    Seattle Top Doctor - 2019 Seattle Magazine 2019
    SEATTLE'S TOP DOCTOR - 2017 Seattle Magazine 2017
  • Publications

    Other Publications

    • Moshiri M, Chapman T, Fechner PY, Dubinsky TJ, Shnorhavorian M, Osman S, Bhargava P, Katz DS
      Evaluation and management of disorders of sex development: multidisciplinary approach to a complex diagnosis.
      23065160 Radiographics : a review publication of the Radiological Society of North America, Inc, 2012 Oct. : 32(6)1599-618
    • Chiu HK, Sanda S, Fechner PY, Pihoker C
      Correlation of TSH with the risk of paediatric thyroid carcinoma.
      22404106 Clinical endocrinology, 2012 Aug. : 77(2)316-22
    • Adam MP, Fechner PY, Ramsdell LA, Badaru A, Grady RE, Pagon RA, McCauley E, Cheng EY, Parisi MA, Shnorhavorian M
      Ambiguous genitalia: what prenatal genetic testing is practical?
      22581420 American journal of medical genetics. Part A, 2012 June : 158A(6)1337-43
    • Davenport ML, Roush J, Liu C, Zagar AJ, Eugster E, Travers S, Fechner PY, Quigley CA
      Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome.
      20424424 Hormone research in paediatrics, 2010 July : 23-32
    • Henry RK, Keil MF, Stratakis CA, Fechner PY
      Cushing's syndrome secondary to isolated micronodular adrenocortical disease (iMAD) associated with rapid onset weight gain and negative abdominal MRI findings in a 3 year old male.
      20662336 Journal of pediatric endocrinology & metabolism : JPEM, 2010 June : 613-20
    • Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, Gunther DF, Liu C, Geffner ME, Thrailkill K, Huseman C, Zagar AJ, Quigley CA
      Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
      17595258 The Journal of clinical endocrinology and metabolism, 2007 Sept. : 3406-16
    • Fechner PY, Davenport ML, Qualy RL, Ross JL, Gunther DF, Eugster EA, Huseman C, Zagar AJ, Quigley CA
      Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age.
      16968797 The Journal of clinical endocrinology and metabolism, 2006 Dec. : 4896-902
    • Leung MY, Steinbach PJ, Bear D, Baxendale V, Fechner PY, Rennert OM, Chan WY
      Biological effect of a novel mutation in the third leucine-rich repeat of human luteinizing hormone receptor.
      16709601 Molecular endocrinology (Baltimore, Md.), 2006 Oct. : 2493-503
    • Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM
      Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
      16155076 Human reproduction (Oxford, England), 2006 Jan. : 109-20
    • Fechner PY
      Gender differences in puberty.
      11943574 The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2002 April : 44-8
  • Presentations

    Presentation Title Event Location Date
    Outcomes in Congenital Hypothyroidism Parent support group Seattle, WA Mar 13, 2009
  • Research Funding

    Grant Title Grantor Amount Award Date
    Genotropin Mark VII pen Pfizer Sep 1, 2009
    Quality of Life in Intersexuality: A Pediatric Clinical and Research Tool National Institute of Child Health and Human Development May 1, 2009
    Efficacy and Safety of Leuprolide Acetate 11.25 and 30 mg formulations Abbott Aug 28, 2008
    Recombinant Human Growth Hormone and Recombinant Human Insulin-like Growth Factor-1 Tercica Apr 4, 2008
    Increlex Growth Forum Database-IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex Tercica Jan 1, 2007
    Effect of Early Growth Hormone Treatment on Long-Term Growth and Skeletal Maturation in Girls with Turner Syndrome Eli Lilly and Company Jan 1, 2006


Board Certification(s)

Pediatric Endocrinology

Medical/Professional School

Massachusetts Institute Of Technology, Cambridge, MA
Northwestern University, Chicago, IL


University of California Irvine-College of Medicin, Irvine, CA


Johns Hopkins University School of Medicine, Baltimore, MD

Clinical Interests

Sex Determination, Congenital Adrenal Hyperplasia, Turner Syndrome, AIS, Growth, Puberty

Research Description

She performs industry sponsored research in the areas of Congenital Adrenal Hyperplasia, Turner Syndrome and growth.

Research Focus Area

Translational Research